Dr Heerajnarain Bulluck Research fellow

Slides:



Advertisements
Similar presentations
Allen Jeremias MD MSc, Sanjay Kaul MD, Luis Gruberg MD, Todd K. Rosengart MD, David L. Brown MD Divisions of Cardiovascular Medicine and Cardiothoracic.
Advertisements

Unstable Angina: Embolism Can Occur Prior to PCI Thrombus in proximal RCA Stain of muscle before injection begins: TIMI Myocardial perfusion grade 1 CM.
Post-conditioning the human heart to reduce infarct size
Cyclosporine A reduces infarct size and has no detrimental effect of LV remodeling in STEMI patients Michel Ovize Cardiology Hospital and Inserm U886 Lyon.
on behalf of the TOTAL Investigators
Ischemic Heart Diseases IHD
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
Beta Blockade and the Heart John Hakim, M.D Cardiology Fellow West Virginia University Division of Cardiology.
Francesco Liistro Cardiovascular Department, Arezzo, Italy Impact of Thrombus Aspiration on Myocardial Tissue Reperfusion and Left Ventricular Functional.
ACUTE CORONARY SYNDROME (ACS). ACS Pathophysiology is that of a ruptured or eroded atheromatous plaque. Pathophysiology is that of a ruptured or eroded.
Clinical Trial Results. org C. Michael Gibson, M.S., M.D. Director TIMI Data Coordinating Center Invasive Cardiologist Beth Israel Deaconess Medical Center.
Murat Sezer, Emre Aslanger, Arif Cimen, Ebru Yormaz, Cuneyt Turkmen, Berrin Umman, Yılmaz Nisanci, Zehra Bugra and Sabahattin Umman Istanbul University,
Minimise the damage – Pre- and Post-conditioning Dr Derek J Hausenloy The Hatter Cardiovascular Institute, University College London, UK. Myocardial Recovery.
Effect of Intracoronary Streptokinase Administered Immediately after Primary PCI on Left Ventricular Infarct Size, Volume and Function (J Am Coll Cardiol.
Angiographic Estimates of Myocardium at Risk During Acute Myocardial Infarction: a Validation Study Using Cardiac MRI José T. Ortiz, Sheridan N. Meyers,
Improving outcome of STEMI PCI: Preliminary Results of Crystal AMI trial Rajesh M. Dave, MD Principal investigator on behalf of Crystal AMI Investigators.
S Reducion of infarction size as a target Mohamed Mahmoud Abd El Ghany Mohamed Mahmoud Abd El Ghany Cardiology Professor of Cairo University.
The index of microvascular resistance measured acutely predicts infarct severity and left ventricular function at 3 months in patients with ST segment.
The Impact of Thrombus Aspiration on 1-year Mortality in Primary PCI for ST-Elevation Myocardial Infarction, ACSIS 2010 Experience Mady Moriel, Shlomi.
Beyond TIMI 3 Flow CTFC < 14 CTFC > % (n=41) (n = 18/640) (n =35/563) 2.8% p= “TIMI 4” Flow TIMI 3 Flow 14 < CTFC < % % Risk of In Hospital.
Can we protect patients undergoing percutaneous coronary intervention better? Beneficial effects of short- and long-term trimetazidine MR therapy in patients.
UNIVERSITÄT LEIPZIG H E R Z Z E N T R U M Infarct transmurality and infarct size assessed by delayed enhancement magnetic resonance imaging: Association.
Late Open Artery Hypothesis Jason S. Finkelstein, M.D. Tulane University Medical Center 2/24/03.
Perindopril Remodeling in Elderly with Acute Myocardial Infarction PREAMIPREAMI Presented at The European Society of Cardiology Hot Line Session, September.
PROTECT: What Have We Learned Lesson 2: TMPG is associated with clinical and biomarker outcomes following PCI.
Intravenous Erythropoietin in Patients with ST-Segment Elevation MI -- Study performed by: Najjar et al -- Presented by: Jay Hall PA-SII, Ali Rahimi MD.
Long Term Benefit Of Early Pre-reperfusion Metoprolol Administration In Patients With Acute Myocardial Infarction: Results From The METOCARD-CNIC trial.
Francone M, Bucciarelli-Ducci C*, Carbone I, Canali E, Scardala R, Calabrese F, Sardella G, Mancone M, Catalano C, Fedele F, Passariello R, Bogaert J**
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
Effect of Thrombus Aspiration in Patients With Myocardial Infarction Presenting Late After Symptom Onset Steffen Desch, MD Thomas Stiermaier, MD; Suzanne.
CHEST 2013; 144(3): R3 김유진 / Prof. 장나은. Introduction 2  Cardiovascular diseases  common, serious comorbid conditions in patients with COPD cardiac.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Aldosterone Blockade in Acute Myocardial Infarction:
Relationship of the TIMI Myocardial Perfusion Grades, Flow Grades, Frame Count, and Percutaneous Coronary Intervention to Long-Term Outcomes After Thrombolytic.
M-Guard stent in STEMI patients with high thrombus burden lesions Mahmoud Shabestari Baktash Bayani Ali Eshraghi Bahram Shahri Mashhad University.
“How we do” CMR in acute myocardial infarction
Howard A. Cohen, MD, FACC,FSCAI Professor of Medicine
British Society of Cardiovascular Magnetic Resonance
The NHLBI TIME Trial: Role of Microvascular Obstruction in 2-Year Clinical and MRI Follow-up Jay H. Traverse, MD Principal Investigator, TIME Study Minneapolis.
Establishing a research network of cardiac MRI centers to investigate cardioprotection in STEMI patients Derek Hausenloy Professor, Cardiovascular and.
The Current Strategies in Treatment of No Reflow
Management of ST-Elevation Myocardial Infarction
Heart Disease in the Acute Hospital
Presenter Disclosure Information
Balloon-pump assisted Coronary Intervention Study (BCIS-1):
The Hidden Cost of Underutilizing PCI for Chronic Total Occlusions
What about CMR in patients with acute MI?
Circ Cardiovasc Interv
Setareh Omran, MD Vascular Neurology Fellow
A. Epidemiology update:
Nat. Rev. Cardiol. doi: /nrcardio
The Role of Stress Cardiac Magnetic Resonance in Women
European Heart Association Journal 2007 April
Alexander Liu et al. JACC 2018;71:
Date: Presenter: Ryan Chen
Nat. Rev. Cardiol. doi: /nrcardio
Published in the European Heart Journal
American College of Cardiology Presented by Dr. Michel R. Le May
Division of Cardiovascular Diseases No relevant author disclosures
Significance of Periprocedural Myocardial Infarctions in Percutaneous Coronary Interventions A New Look at an Old Topic Abhiram Prasad, MD, FRCP, FESC,
Flow diagram for exclusions of trials identified RCT indicates randomized controlled trial Hulten E, et al. Arch Intern Med 2006;166:
Infarct Size after Primary Angioplasty Patients With Bivalirudin
Dye strongly persistent
Association of Troponin Elevation with Risk of Mortality in Acute Coronary Syndromes Mortality at 42 Days  % A study by Antman and.
T2DM patients with HF may benefit from SGLT2 inhibitor therapy
Clinical benefit of adenosine as an adjunct to reperfusion in ST-elevation myocardial infarction patients: An updated meta-analysis of randomized controlled.
A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.
GUSTO 1 Trial 41,000 patients enrolled, landmark study
Figure 5. Concept of coronary flow reserve and IMR
CIRCUS Trial design: Patients with anterior STEMI were randomized to IV cyclosporine 2.5 mg/kg (n = 475) vs. placebo (n = 495) immediately before coronary.
16-year follow-up of the DANish Acute Myocardial Infarction 2 (DANAMI-2) trial PG Thranea, SD Kristensena, KKW Olesena, LS Mortensenb, HE Bøtkera, L.
Presentation transcript:

Detecting Microvascular Obstruction in STEMI Patients at the Time of PPCI Dr Heerajnarain Bulluck Research fellow The Hatter Cardiovascular Institute, UCL, London, UK National Heart Centre Singapore, Singapore JCR 2016, Busan, South Korea

Contents Background Methods Results Conclusions

Background Mortality due to STEMI is in decline but morbidity and mortality due to post-MI heart failure is on the rise Partly attributed to reperfusion injury: No reflow/microvascular obstruction MVOadverse LV remodellingheart failure New therapies required to prevent MVO

Cardiac MRI (first week) STEMI Chest pain PPCI Cardiac MRI (first week) Acute myocardial ischaemia Reperfusion

Acute STEMI

Acute anterior STEMI

Bulluck et al, Heart 2015 Jul;101(13):1067-77 Onset of STEMI Bulluck et al, Heart 2015 Jul;101(13):1067-77 100 Reperfusion via PPCI or thrombolysis Loss of viable myocardium due to Ischaemia – Reperfusion Injury, a target for cardioprotection MYOCARDIAL SALVAGE (% of LV) Expected myocardial salvage No salvage without reperfusion Actual myocardial salvage TIME (Hours) 12

or microvascular obstruction Ischemia – Reperfusion Injury (IRI) Lethal myocardial reperfusion injury Myocardial stunning Reperfusion arrhythmias Coronary no reflow or microvascular obstruction Due to the opening of the MPTP and irreversible cardiomyocyte hypercontracture from: Ca+ overload Oxidative stress Rapid restoration in intracellular pH Transient and self-limiting Self-terminating or is usually easily treated As a result of: External compression of capillaries Release of vasoactive substances Extravasation of RBC Neutrophil plugging Embolization of plaques and thrombi In-situ thrombi formation Reversible Irreversible

Patent epicardial coronaries Heart Microcirculation Extravasated RBCs Extrinsic compression by swollen cardiomyocytes Fibrin Endothelial swelling Micro-thrombi Coronary veins Platelet aggregation Endothelial blebs Rouleaux formation Capillary Neutrophil plugging

Van Kranenberg et al. JACC Cardiovasc Imaging. 2014 Sep;7(9):930-9

Assessing the microvascular circulation TIMI flow grade MBG/ TMPG ST-segment resolution Contrast-enhanced echocardiography CMR Cardiac CT Invasive measure of microvascular resistance: index of microvascular resistance (IMR)

IMR – Mean Transit Time

IMR IMR= Pd x Tmn at hyperaemia

Background Studies have assessed the relationship between IMR and MVO by CMR But results not consistent Underpowered

Aim To conduct a meta-analysis to investigate the role of IMR in detecting the presence of MVO at the time of PPCI in reperfused STEMI patients.

Methods We searched MEDLINE and EMBASE databases up to June 2016 The inclusion criteria were those studies undertaking both IMR at the end of PPCI in STEMI patients and performing CMR to detect MVO We only included studies reporting the mean IMR in patients with and without MVO

Results Six studies were included in the meta-analysis, comprising a total of 288 patients MVO data by CMR was available for 246 patients MVO was present in 130/246 (53%) patients

Results The weighted mean IMR of the whole cohort was 38.6 (99%CI 33.5-43.6)U. The weighted mean IMR in the 130 patients with MVO was 49.1 (99%CI 41.4-56.8)U and 26.7(99%CI 21.6-32.0)U(P<0.0001; heterogeneity; I2=0%) in 116 patients without MVO

Patients with a weighted mean IMR <32U (upper limit of the 99%CI in the group without MVO) were far less likely to have MVO, whereas those with a weighted mean IMR >41U (lower limit of the 99%CI in the group with MVO) were much more likely to have MVO Fearon et al (Circulation. 2013 Jun 18;127(24):2436-41.): median IMR value of >40U was an independent predictor of death in 253 STEMI patients (hazard ratio 4.3, P 0.02) after a median follow-up of 2.8 years Carrick et al (Circulation. 2016 Dec 6;134(23):1833-1847.): also showed that an IMR >40U was a multivariable associate of adverse LV remodeling by CMR at 6 months, and was a better predictor of all-cause death or heart failure than the duration of ischemia, ST-segment resolution, TMPG and CFR after a median follow-up of 845 days.

Conclusions This study suggest that patients with a weighted mean IMR <32U were far less likely to have MVO, whereas patients with a weighted mean IMR >41U were much more likely to have MVO We would propose that when investigating a novel intervention for preventing MVO, selecting patients with an IMR>41U may help identify those most likely to benefit from the treatment

JACC Cardiovasc Interv. 2016 Oct 24;9(20):2172-2174. doi: 10. 1016/j JACC Cardiovasc Interv. 2016 Oct 24;9(20):2172-2174. doi: 10.1016/j.jcin.2016.08.018. Index of Microvascular Resistance and Microvascular Obstruction in Patients With Acute Myocardial Infarction. Bulluck H, Foin N, Cabrera-Fuentes HA, Yeo KK, Wong AS, Fam JM, Wong PE, Tan JW, Low AF, Hausenloy DJ.